{"context":{"query":">>hgnc>>gwas","source_dataset":"hgnc","target_dataset":"gwas"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]HGNC:613,10,HGNC:613,155,1]["},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"HGNC:613","source":"HGNC:613|apolipoprotein E","targets":["GCST000018_1|Alzheimer's disease (late onset)|APOC1|19|1.000000e-39","GCST000121_1|Alzheimer's disease|APOC1|19|1.000000e-39","GCST000124_1|Alzheimer's disease|APOC1|19|2.000000e-44","GCST000132_2|LDL cholesterol|APOC1|19|3.000000e-43","GCST000134_3|LDL cholesterol|APOC1|19|1.000000e-60","GCST000178_6|C-reactive protein|APOE|19|9.000000e-21","GCST000179_2|C-reactive protein|TOMM40|19|1.000000e-07","GCST000234_2|LDL cholesterol|APOC1|19|2.000000e-07","GCST000237_1|Alzheimer's disease|NECTIN2|19|6.000000e-14","GCST000282_7|LDL cholesterol|TOMM40|19|2.000000e-19","GCST000285_7|Cholesterol, total|TOMM40|19|3.000000e-19","GCST000287_9|LDL cholesterol|APOC1|19|4.000000e-27","GCST000288_4|HDL cholesterol|TOMM40|19|4.000000e-07","GCST000289_3|Triglycerides|APOE - APOC1|19|2.000000e-09","GCST000313_1|Alzheimer's disease|TOMM40|19|1.000000e-40","GCST000337_15|Quantitative traits|APOC1|19|5.000000e-06","GCST000337_19|Quantitative traits|APOC1|19|3.000000e-07","GCST000337_29|Quantitative traits|APOC1|19|2.000000e-06","GCST000430_5|C-reactive protein|APOC1|19|5.000000e-27","GCST000479_3|Alzheimer's disease|TOMM40|19|2.000000e-157","GCST000480_3|Alzheimer's disease|TOMM40|19|2.000000e-16","GCST000484_5|Alzheimer's disease|TOMM40|19|3.000000e-11","GCST000573_11|Brain imaging|APOE|19|1.000000e-09","GCST000573_5|Brain imaging|APOE|19|1.000000e-07","GCST000682_1|Alzheimer's disease|TOMM40|19|1.000000e-295","GCST000755_36|HDL cholesterol|APOC1|19|4.000000e-21","GCST000758_8|Triglycerides|APOE - APOC1|19|1.000000e-30","GCST000759_24|LDL cholesterol|APOC1|19|9.000000e-147","GCST000760_4|Cholesterol, total|APOC1|19|5.000000e-111","GCST000807_5|LDL cholesterol|APOC1|19|2.000000e-40","GCST000808_2|Alzheimer's disease (late onset)|TOMM40|19|5.000000e-36","GCST000900_6|Alzheimer's disease biomarkers|APOE|19|1.000000e-06","GCST001013_1|Longevity|TOMM40|19|3.000000e-17","GCST001087_2|Alzheimer's disease|TOMM40|19|8.000000e-89","GCST001237_6|HDL cholesterol|NECTIN2|19|8.000000e-11","GCST001280_7|Alzheimer's disease (age of onset)|APOC1|19|1.000000e-12","GCST001285_11|Psychosis and Alzheimer's disease|TOMM40|19|9.000000e-52","GCST001311_1|Cognitive decline|APOC1|19|4.000000e-27","GCST001372_1|Alzheimer's disease|||4.000000e-09","GCST001372_2|Alzheimer's disease|||7.000000e-16","GCST001392_14|Lipid metabolism phenotypes|APOE|19|3.000000e-58","GCST001408_4|Response to statins (LDL cholesterol change)|APOE|19|2.000000e-47","GCST001436_10|Metabolic syndrome|TOMM40|19|1.000000e-08","GCST001529_1|Alzheimer's disease|APOC1|19|8.000000e-149","GCST001530_1|Hippocampal atrophy|||2.000000e-33","GCST001530_11|Hippocampal atrophy|||1.000000e-07","GCST001639_29|Metabolite levels|APOE - APOC1|19|6.000000e-42","GCST001645_1|LDL cholesterol|APOE|19|2.000000e-09","GCST001703_3|Apolipoprotein Levels|APOE - APOC1|19|2.000000e-14","GCST001727_7|Lipoprotein-associated phospholipase A2 activity and mass|APOE - APOC1|19|1.000000e-56","GCST001814_22|Age-related macular degeneration|TOMM40|19|1.000000e-06","GCST001814_31|Age-related macular degeneration|LNCOB1, NECTIN2|19|1.000000e-06","GCST001814_8|Age-related macular degeneration|TOMM40|19|3.000000e-06","GCST001868_13|Alzheimer's disease biomarkers|APOE|19|5.000000e-14","GCST001884_16|Age-related macular degeneration|APOC1|19|2.000000e-20","GCST001947_2|Alzheimer's disease (late onset)|NECTIN2|19|5.000000e-39","GCST001951_2|Alzheimer's disease biomarkers|APOE|19|2.000000e-16","GCST001951_3|Alzheimer's disease biomarkers|APOE|19|2.000000e-18","GCST002042_4|LDL cholesterol|TOMM40|19|2.000000e-21","GCST002086_1|C-reactive protein|TOMM40|19|2.000000e-21","GCST002174_1|Lipid traits|APOE|19|3.000000e-53","GCST002174_2|Lipid traits|APOE|19|2.000000e-30","GCST002221_53|Cholesterol, total|APOC1|19|1.000000e-149","GCST002222_52|LDL cholesterol|APOC1|19|2.000000e-178","GCST002223_36|HDL cholesterol|APOC1|19|2.000000e-21","GCST002320_1|Cognitive decline (age-related)|APOE|19|5.000000e-19","GCST002403_4|Longevity (85 years and older)|APOC1|19|2.000000e-26","GCST002404_1|Longevity (90 years and older)|APOC1|19|3.000000e-36","GCST002422_1|Alzheimer's disease|TOMM40|19|9.000000e-116","GCST002429_1|Alzheimer's disease|TOMM40|19|4.000000e-13","GCST002531_2|Cerebrospinal AB1-42 levels in Alzheimer's disease dementia|APOE|19|4.000000e-17","GCST002591_11|Lewy body disease|APOE|19|3.000000e-11","GCST002591_2|Lewy body disease|APOE|19|5.000000e-12","GCST002591_38|Lewy body disease|APOE|19|1.000000e-12","GCST002675_6|Response to statins (LDL cholesterol change)|APOE - APOC1|19|9.000000e-29","GCST002690_17|Very long-chain saturated fatty acid levels (fatty acid 20:0)|APOC4-APOC2, APOC2|19|4.000000e-06","GCST002701_25|Verbal declarative memory|APOC1|19|1.000000e-16","GCST002701_5|Verbal declarative memory|APOC1|19|6.000000e-13","GCST002701_6|Verbal declarative memory|APOC1|19|2.000000e-12","GCST002701_7|Verbal declarative memory|APOC1|19|1.000000e-16","GCST002896_15|Cholesterol, total|APOE|19|8.000000e-239","GCST002897_32|Triglycerides|APOC1|19|9.000000e-37","GCST002898_1|LDL cholesterol|APOE - APOC1|19|4.940656e-324","GCST002899_19|HDL cholesterol|APOE|19|1.000000e-14","GCST002983_3|Alzheimer's disease (late onset)|TOMM40|19|8.000000e-11","GCST003073_10|Cerebral amyloid deposition (PET imaging)|APOE|19|8.000000e-32","GCST003077_1|Cerebral amyloid deposition positivity (PET imaging)|APOE|19|5.000000e-20","GCST003113_4|Cingulate cortical amyloid beta load|APOE|19|5.000000e-17","GCST003116_24|Coronary artery disease|APOC1|19|7.000000e-11","GCST003217_9|Triglycerides|TOMM40|19|4.000000e-22","GCST003219_47|Advanced age-related macular degeneration|APOE|19|2.000000e-42","GCST003219_48|Advanced age-related macular degeneration|MARK4, EXOC3L2|19|3.000000e-07","GCST003279_1|Ideal cardiovascular health (clinical)|APOE - APOC1|19|9.000000e-10","GCST003361_1|LDL cholesterol levels|TOMM40|19|3.000000e-06","GCST003427_20|Alzheimer disease and age of onset|APOC1|19|2.000000e-16","GCST003435_18|Body fat percentage|LNCOB1, NECTIN2|19|7.000000e-07","GCST003435_26|Body fat percentage|LNCOB1, NECTIN2|19|7.000000e-10","GCST003435_39|Body fat percentage|LNCOB1, NECTIN2|19|2.000000e-07","GCST003435_6|Body fat percentage|LNCOB1, NECTIN2|19|7.000000e-09","GCST003452_1|Posterior cortical atrophy and Alzheimer's disease|TOMM40|19|6.000000e-14"]}]}